Related Experiment Video
Updated: Aug 25, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Genetic Basis of Childhood Cardiomyopathy
Richard D Bagnall1,2, Emma S Singer1,2, Julie Wacker3
1Agnes Ginges Centre for Molecular Cardiology at Centenary Institute, University of Sydney, Sydney, NSW, Australia (R.D.B., E.S.S., N.N., J.I., J.C., C.S.).
Insights
Genetic testing helps diagnose childhood cardiomyopathy, identifying specific causes and informing prognosis. This research evaluated clinical diagnoses and genetic factors in pediatric cardiomyopathy patients.
Area of Science:
- Genetics
- Pediatric Cardiology
- Molecular Biology
Background:
- Childhood cardiomyopathy causes are less understood than in adults.
- This study focuses on clinical diagnoses and genetic underpinnings of pediatric cardiomyopathy.
- It also examines the effectiveness of cascade genetic testing in family members.
Purpose of the Study:
- To evaluate clinical diagnoses and genetic causes of cardiomyopathy in children.
- To assess the outcomes of cascade genetic testing in families of affected children.
- To improve understanding and diagnosis of pediatric heart muscle diseases.
Main Methods:
- Recruited pediatric patients from cardiology and genetic heart disease clinics.
- Employed various genetic sequencing techniques (Sanger, gene panel, exome, genome).
- Classified genetic variants using established American College of Molecular Genetics and Genomics guidelines.
Main Results:
- 221 children diagnosed with cardiomyopathy; hypertrophic and dilated types were most common.
- Highest diagnostic yields for genetic testing were in restrictive (80%) and hypertrophic (66%) cardiomyopathy.
- Pathogenic variants in sarcomere protein genes were frequent; TNNT2 and TNNI3 variants correlated with severe outcomes. Cascade testing identified de novo, recessive, and reclassified variants.
Conclusions:
- Genetic testing aids in precise clinical diagnosis of childhood cardiomyopathy.
- Diagnosis through genetic analysis can inform patient prognosis.
- Understanding genetic causes is crucial for managing pediatric heart conditions.
Background:
The causes of cardiomyopathy in children are less well described than in adults. We evaluated the clinical diagnoses and genetic causes of childhood cardiomyopathy and outcomes of cascade genetic testing in family members.
Methods:
We recruited children from a pediatric cardiology service or genetic heart diseases clinic. We performed Sanger, gene panel, exome or genome sequencing and classified variants for pathogenicity using American College of Molecular Genetics and Genomics guidelines.
Results:
Cardiomyopathy was diagnosed in 221 unrelated children aged ≤18 years. Children mostly had hypertrophic cardiomyopathy (n=98, 44%) or dilated cardiomyopathy (n=89, 40%). The highest genetic testing diagnostic yields were in restrictive cardiomyopathy (n=16, 80%) and hypertrophic cardiomyopathy (n=65, 66%), and lowest in dilated cardiomyopathy (n=26, 29%) and left ventricular noncompaction (n=3, 25%). Pathogenic variants were primarily found in genes encoding sarcomere proteins, with TNNT2 and TNNI3 variants associated with more severe clinical outcomes. Ten children (4.5%) had multiple pathogenic variants. Genetic test results prompted review of clinical diagnosis in 14 families with syndromic, mitochondrial or metabolic gene variants. Cascade genetic testing in 127 families confirmed 24 de novo variants, recessive inheritance in 8 families, and supported reclassification of 12 variants.
Conclusions:
Genetic testing of children with cardiomyopathy supports a precise clinical diagnosis, which may inform prognosis.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...

